HYFER Tablet

ក្រុមហ៊ុនផលិតឱសថ:

 

ALICE PHARMA PVT. LTD., india

  • សារធាតុសកម្ម
  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់
  • ហាមប្រើ
  • ផលរំខាន
  • អន្តរប្រតិកម្ម
  • ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន
  • ការប្រុងប្រយ័ត្នជាពិសេស
  • បរិយាយប័ណ្ណឱសថ 
  • សារធាតុសកម្ម

    Iron 100mg, Folic acid 1.5mg, Ascorbic acid (Vitamin-C) 75mg, Cyanocobalamin (Vitamin-B12) 15mcg, Zinc 22.5 mg

  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់

    INDICATIONS:

    ・Curative treatment of asiderotic anaemia (minimum 4 to 6 months of treatment in association with an etiologic treatment).

    ・In the treatment of iron-deficiency in exposed subjects, pregnant women, unbalanced food diets (old patients, vegetarians, mental anorexia), chronic bleeding. megaloblastic anaemia by lack of folic acid.

    ・Chronic disorder of intestinal absorption (malabsorption, celiac disease, strong digestive resection).

    ・Lack of folate: malnutrition, chronic alcoholism.

    ADMINISTRATION AND USES:

    Always take Hyfer exactly as your doctor has instructed you. You should check with your doctor or pharmacist if you are unsure. This medicine must be taken by oral route. For children under 6 years, oral route is inappropriate following wrong route risk, and only syrup form should be used.

    Tablets:

    To take before meal with a glass of water.

    - In the treatment of iron-deficiency anaemia:

    Children older than 6 years: the intake is related to the iron dosage in the body. 6 to 10 mg/kg/day in 1 or 2 intakes during at least 4 to 6 months in association with etiologic treatment.

    syrup form will be most indicated for children.

    - support dosage

    Adult: 1 tablet daily

  • ហាមប្រើ

    Martial overload.

    Isolated use in deficiency in vitamin B12.

    Allergy to one of the components.

    Megaloblastic anaemia without diagnostic.

    Tablet form is not suitable for children under six years.

  • ផលរំខាន

    Like all medicines, Hyfer can have side effects.

    Gastro-intestinal irritation and abdominal pain with nausea and vomiting are rare.

    Other effects include diarrhea or constipation.

    The faeces of patients taking iron salts may be coloured black.

  • អន្តរប្រតិកម្ម

    Please inform your doctor or your pharmacist if you are taking or have recently taken any other medicines, even those not prescribed.

    - Iron absorption is impaired when associated with anti-acidity stomach drugs.

    - The concomitant administration of tetracycline produces a resorption decrease (a suitable interval of 2 or 3 hours is required.

    - iron salts reduce the absorption and bioavailability of other drugs, among them the levodopa, the methyldopa, the penicillamine and fluoroquinolones like ciprofloxacin and ofloxacine.

    - Some food components like phytines (coming from cereals) or pohosphates can form compounds that are insoluble with iron.

    - Zinc salts may reduce absorption of iron.

    - An excessive consumption of tea may inhibit the absorption of iron.

    - The resorption of folic acid is reduced by ethanol and phenytoine.

    - Barbiturics, cycloserine and oral contraceptives induce a decrease in the plasma concentration of folic acid.

    ・The methotrexate, the pyrimethamine, the trimethoprime and triamterene, that are folic acid antagonists, may produce anaemia.

    - The folic acid has an antagonist action with sulfamides.

    - Some tuberculostatic drugs may have an influence on the folic acid action.

  • ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន

    Hyfer dose not represent any risk for pregnant and breastfeeding women at prescribed doses.

  • ការប្រុងប្រយ័ត្នជាពិសេស

    Warning:

    The excessive and prolonged use or the combination with other ferrous preparations can produce iron intoxication.

    This formulation must be administered with the greatest caution to epileptic patients under treatment.

    Precautions of use:

    Hyfer treatment requires first a causal diagnostic.

    Caution and driving:

    Hyfer has no influence on this kind of activity.

*ព័ត៌មានឱសថត្រូវបានរៀបរៀងដោយ អ៊ីម៉ាតុគឹ មេឌីក (ខេមបូឌា) ដោយផ្អែកលើប្រភពព័ត៌មានខាងក្រោម។ សម្រាប់ព័ត៌មានលម្អិត សូមស្វែងរកនៅក្នុងក្រដាសព័ត៌មាននៃឱសថនីមួយៗ ឬ សាកសួរទៅកាន់ក្រុមហ៊ុនឱសថឬតំណាងចែកចាយនៃឱសថនីមួយៗ។

ប្រភពព័ត៌មាន៖

- ក្រដាសព័ត៌មាននៃឱសថសម្រាប់អ្នកជំនាញវេជ្ជសាស្ត្រដែលប្រើប្រាស់នៅប្រទេសជប៉ុន (Pharmaceutical and Medical Devices Agency, Pmda): https://www.pmda.go.jp

- ព័ត៌មានសង្ខេបនៃឱសថសម្រាប់អ្នកជំងឺដែលប្រើប្រាស់នៅប្រទេសជប៉ុន: http://www.rad-ar.or.jp